跳至主要内容
临床试验/NCT06597695
NCT06597695招募中1 期

A Ketamine-assisted Group Therapy Intervention for Spanish-speaking Adults With Depression

Juliana Zambrano, MD, MPH2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2025年7月23日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
招募中
入组人数
10
试验地点
2
主要终点
Evaluate feasibility of a culturally adapted group-based ketamine intervention for Spanish- speaking adults with depression in a community setting

研究概览

简要总结

This is a pilot clinical trial to assess the feasibility, safety, and preliminary efficacy of ketamine-assisted group therapy for Spanish-speaking adults with depression

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 1. Self-identifying Latinx, Spanish-speaking
  • Adults 18-64 years
  • Meet DSM-5 criteria for major depressive disorder as evaluated by study clinician
  • Montgomery-Asberg depression scale (MADRS) score of 20 or above at baseline
  • Participants must have an MGB psychiatrist and primary care provider.

排除标准

  • History of primary psychotic disorder, by history
  • History Bipolar I disorder, by history
  • Unstable complex PTSD, as assessed by study clinician
  • History of dissociative identity disorder
  • History of neurocognitive disorder
  • History of severe and/or recent substance use disorder, by history and as assessed by study clinician after clinical evaluation and interview
  • Uncontrolled hypertension, tachycardia, or unstable cardiopulmonary disease, by history a. Blood pressure on initial screen must be <140/90 mmHg.
  • History of aortic dissection
  • History of myocardial infarction
  • History of aneurysm
  • History of hepatic impairment.
  • History of epilepsy
  • History of prior hypersensitivity to ketamine
  • Body Mass Index greater than 35
  • Body Mass Index less than 18.5
  • Are pregnant, breastfeeding, or planning to become pregnant within 12 weeks of treatment completion
  • Enrolled in other clinical trial for the treatment of depression or other behavioral health diagnosis
  • Inability to provide consent.

研究组 & 干预措施

Open label

Experimental

Open label, single arm study

干预措施: Ketamine-assisted psychotherapy (Drug)

结局指标

主要结局

Evaluate feasibility of a culturally adapted group-based ketamine intervention for Spanish- speaking adults with depression in a community setting

时间窗: 1 week post-intervention

(a) Assess the attendance and adherence rates of participants to the group-based ketamine intervention sessions; (b) Evaluate the feasibility of delivering the intervention sessions as planned, including the preparatory, dosing, and integration sessions; (c) Explore the perceptions and experiences of Spanish-speaking participants regarding the intervention.

To assess the safety of a ketamine-assisted group psychotherapy intervention for Spanish-speaking participants with depression in a community setting.

时间窗: 1 week post-intervention

(a) assess safety as obtained through vital monitoring; heart-rate variability (HRV) monitoring, EKG, as measured by a Fitbit. (b) evaluate physical and psychological adverse effects at each study visit.

次要结局

  • Investigate the preliminary efficacy of the group-based ketamine intervention on psychiatric symptoms, wellbeing, and health behaviors among Spanish-speaking participants with depression.(1 and 12 weeks post-intervention)

研究者

申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Juliana Zambrano, MD, MPH

Psychiatrist

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验

A Ketamine-assisted Group Therapy Intervention for... | 临床试验